Abstract
More than a quarter of the elderly and senile age population suffers from kidney pathology. For this reason, a prophylaxis of kidney diseases with safe and effective nephroprotectors is a priority of gerontology. This work studies the influence of the polypeptide kidney complex (PKC) and peptides AED, EDL, and AEDG, on the functional state of kidneys in old rats. The administration of the PKC and peptides AED and EDL increased diuresis by 1.2–1.4 times. The PKC and peptide AED reduced the urine protein level and protein excretion by 1.5–2.8 times. The PKC and peptides AED and EDL increased distal sodium transport by 1.2–1.3 times. The peptides AED and EDL increased sodium excretion by 1.3 and 1.6 times respectively. The renal effects of the peptide AEDG resulted in a 21% reduction of glomerular filtration rate, a 3.1-fold decrease in the urine protein level, and a 2.5-fold decrease in protein excretion. The peptide AEDG reduced absolute sodium reabsorption by 1.3 times and increased distal sodium transport by 1.4 times. The realization of glomerular–tubular and tubular–tubular balances is verified by the correlation between the glomerular filtration rate (GFR) and absolute, proximal, and distal sodium reabsorption. In kidney tissue, stimulation of the antioxidant enzyme activity on the background of inhibition of the intensity peroxidation processes was observed, which, together with morphological data, reflects the absence of nephrotoxic effects. PKC and peptides AED, EDL, and AEDG may be considered nephroprotective agents in kidney aging.
Similar content being viewed by others
REFERENCES
Arutyunyan, A.V., Dubinina, E.E., and Zybina, N.N., Metody otsenki svobodnoradikal’nogo okisleniya i antioksidantnoi sistemy organizma: Metodicheskie rekomendatsii (Evaluation of Free Radical Oxidation and Antioxidant System of Organism: Methodological Recommendations), St. Petersburg, 2000.
Zamorskii, I.I. and Shchudrova, T.S., Main mechanisms of rhabdomyolysis-caused kidney injury and their correction by organospecific peptides, Biophysics (Moscow), 2014, vol. 59, no. 5, pp. 834–836.
Zamorskii, I.I., Shchudrova, T.S., Lin’kova, N.S., Nichik, T.E., and Khavinson, V.K., Peptides restore functional state of the kidneys during cisplatin-induced acute renal failure, Bull. Exp. Biol. Med., 2015, vol. 159, no. 6, pp. 736–739.
Zamorskii, I.I., Shchudrova, T.S., Lin’kova, N.S., Nichik, T.E., and Khavinson, V.K., Nephroprotective effect of EDL peptide at acute injury of kidneys of different genesis, Bull. Exp. Biol. Med., 2017, vol. 163, no. 3, pp. 389–393.
Metody klinicheskikh laboratornykh issledovanii (Methods of Clinical Laboratory Studies), Kamyshnikov, V.S., Ed., Moscow: MEDpressinform, 2016, 8th ed.
Ryzhak, A.P., Chalisova, N.I., Lin’kova, N.S., et al., Effect of polypeptides on cell proliferation and apoptosis during aging, Bull. Exp. Biol. Med., 2017, vol. 162, no. 4, pp. 534–538.
Khavinson, V.Kh., Lin’kova, N.S., Polyakova, V.O., Durnova, A.O., Nichik, T.E., and Kvetnoi, I.M., Peptides regulate expression of signaling molecules in kidney cell cultures during in vitro aging, Bull. Exp. Biol. Med., 2014, vol. 157, no. 2, pp. 261–264.
Chalisova, N.I., Lin’kova, N.S., Nichik, T.E., et al., Peptide regulation of cells renewal processes in kidney tissue cultures from young and old animals, Bull. Exp. Biol. Med., 2015, vol. 159, no. 1, pp. 124–127.
Shtrygol’, S.Yu., Tovchiga, O.V., Koiro, O.O., and Shchekina, E.G., New perspectives of nephroprotection, Bukovins’kii Med. Visn., 2012, vol. 16, no. 3 (63), pp. 35–37.
Ahmad, Q.Z., Jahan, N., Ahmad, G., and Tajuddin, J., Appraisal of nephroprotection and the scope of natural products in combating renal disorders, Nephrol. Ther., 2014, vol. 4, no. 170. https://doi.org/10.4172/2161-0959.1000170
Directive 2010/63/EU of the European Parliament and of the Council on the protection of animals used for scientific purposes, Off. J. Eur. Union, 2010, vol. 53, no. L276/33, pp. 33–80. doi 10.3000/17252555.L_2010.276.eng
Gansevoort, R.T., Correa-Rotter, R., Hemmelgarn, B.R., et al., Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention, Lancet, 2013, vol. 382, pp. 339–352.
Hill, N.R., Fatoba, S.T., Oke, J.L., et al., Global prevalence of chronic kidney disease—a systematic review and meta-analysis, PLoS One, 2016, vol. 11, no. 7, p. e0158765. https://doi.org/10.1371/journal.pone.0158765
Jha, V., Garcia-Garcia, G., Iseki, K., et al., Chronic kidney disease: global dimension and perspectives, Lancet, 2013, vol. 382, pp. 260–272.
Khavinson, V.Kh., EU Patent 1 179 008, 2006.
Khavinson, V.Kh., Grigoriev, E.I., Malinin, V.V. and Ryzhak, G.A., EA Patent 010 156, 2008.
Khavinson, V.Kh., Grigoriev, E.I., Malinin, V.V. and Ryzhak, G.A., EA Patent 010 574, 2008.
Khavinson, V.Kh., Malinin, V.V. and Ryzhak, G.A., EA Patent 010723, 2008.
Matsushita, K., van der Velde, M., Astor, B.C., et al., Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts, Lancet, 2010, vol. 375, pp. 2073–2081. https://doi.org/10.1016/S0140-6736(10)60674-5
Author information
Authors and Affiliations
Corresponding authors
Additional information
Translated by I. Matiulko
Rights and permissions
About this article
Cite this article
Zamorskii, I.I., Shchudrova, T.S., Zeleniuk, V.G. et al. The Influence of Peptides on the Morphofunctional State of Kidneys in Old Rats. Adv Gerontol 9, 75–80 (2019). https://doi.org/10.1134/S207905701901017X
Published:
Issue Date:
DOI: https://doi.org/10.1134/S207905701901017X